LEADER 00000cam  22007814a 4500 
001    70164448 
003    OCoLC 
005    20101105034441.0 
007    cr unu---||||| 
008    060615s2006    maua     b    101 0 eng   
010    2006019883 
020    1573316415 (alk. paper) 
020    9781573316415 (alk. paper) 
035    (OCoLC)70164448 
042    pcc 
050 00 RC660.A15|bI46 2006 
050 14 Q11|b.N47 v.1079 2006 
082 00 616.4/62079|222 
245 00 Immunology of diabetes IV|h[Electronic Resource] :
       |bprogress in our understanding /|cedited by Carani B. 
       Sanjeevi and Toshiaki Hanafusa 
246 3  Immunology of diabetes 4 
246 3  Immunology of diabetes four 
260    Boston, Mass. :|bBlackwell Pub. on behalf of the New York 
       Academy of Sciences,|c2006 
300    1 online resource (xv, 401 p.) :|bill.  
490 1  Annals of the New York Academy of Sciences,|x0077-8923 ;
       |vv. 1079 
504    Includes bibliographical references and index 
505 0  A mini meta-analysis of studies on CD4+CD25+ T cells in 
       human type 1 diabetes: report of the Immunology of 
       Diabetes Society T Cell Workshop -- HLA class I epitope 
       discovery in type 1 diabetes: independent and reproducible
       identification of proinsulin epitopes of CD8 T cells--
       report of the IDS T Cell Workshop Committee -- Genetics of
       fulminant type 1 diabetes -- Why is type 1 diabetes 
       uncommon in Asia? -- Association of SUMO4, as a candidate 
       gene for IDDM5, with susceptibility to type 1 diabetes in 
       Asian populations -- The gene for human IL-21 and genetic 
       susceptibility to type 1 diabetes in the Japanese -- 
       Genetics of type 1 diabetes: similarities and differences 
       between Asian and Caucasian populations -- 
       Immunopathological and genetic features in slowly 
       progressive insulin-dependent diabetes mellitus and latent
       autoimmune diabetes in adults -- Genes influencing innate 
       and acquired immunity in type 1 diabetes and latent 
       autoimmune diabetes in adults -- Progression of autoimmune
       diabetes: slowly progressive insulin-dependent diabetes 
       mellitus or latent autoimmune diabetes of adult -- 
       Immunomodulation for the prevention of SPIDDM and LADA -- 
       Heightened interferon-alpha/beta response causes myeloid 
       cell dysfunction and promotes T1D pathogenesis in NOD mice
       -- Immunolocalization of monocyte chemoattractant protein-
       1 in islets of NOD mice during cyclophosphamide 
       administration -- Young NOD mice show increased diabetes 
       sensitivity to low doses of streptozotocin -- Contribution
       of class III MHC to susceptibility to type 1 diabetes in 
       the NOD mouse -- MHC-linked susceptibility to type 1 
       diabetes in the NOD mouse: further localization of Idd16 
       by subcongenic analysis -- Long-term prevention of 
       diabetes and marked suppression of insulin autoantibodies 
       and insulitis in mice lacking native insulin B9-23 
       sequence -- Eicosanoid imbalance in the NOD mouse is 
       related to a dysregulation in soluble epoxide hydrolase 
       and 15-PGDH expression -- Pancreatic autoimmunity 
       induction with insulin B:9-23 peptide and viral mimics in 
       the NZB mouse -- Viruses cause type 1 diabetes in animals 
       -- Characterization of PAF-AH Ib1 in NOD mice: PAF-AH may 
       not be a candidate gene of the diabetes susceptibility 
       Idd4.1 locus -- Peptide-pulsed immature dendritic cells 
       reduce response to beta cell target antigens and protect 
       NOD recipients from type I diabetes -- New members of the 
       interleukin-12 family of cytokines: IL-23 and IL-27 
       modulate autoimmune diabetes -- Glutamic acid 
       decarboxylase-specific CD4+ regulatory T cells -- 
       Metabolism genes are among the differentially expressed 
       ones observed in lymphomononuclear cells of recently 
       diagnosed type 1 diabetes mellitus patients -- In vitro 
       TNF-alpha and IL-6 production by adherent peripheral blood
       mononuclear cells obtained from type 1 and type 2 diabetic
       patients evaluated according to the metabolic control -- T
       cell immunity to glutamic acid decarboxylase in fulminant 
       type 1 diabetes without significant elevation of serum 
       amylase -- Expression levels of CXC chemokine receptors 3 
       are associated with clinical phenotype of type 1 diabetes 
       -- HLA class I epitope discovery in type 1 diabetes -- 
       Upregulation of Foxp3 expression in mouse and human Treg 
       is IL-2/STAT5 dependent: implications for the NOD STAT5B 
       mutation in diabetes pathogenesis -- Normal T cell 
       development in the absence of thymic insulin expression --
       Antigenic determinants to GAD autoantibodies in patients 
       with type 1 diabetes with and without autoimmune thyroid 
       disease -- TSH receptor antibodies in subjects with type 1
       diabetes mellitus -- Time-resolved fluorescence imaging of
       islet cell autoantibodies -- MHC class I chain-related 
       gene-A is associated with IA2 and IAA but not GAD in 
       Swedish type 1 diabetes mellitus -- Predominance of the 
       group A killer Ig-like receptor haplotypes in Korean 
       patients with T1D -- Frequency of CTLA-4 gene CT60 
       polymorphism may not be affected by vitamin D receptor 
       gene Bsm I polymorphism or HLA DR9 in autoimmune-related 
       type 1 diabetes in the Japanese -- Genetic and functional 
       evidence supporting SUMO4 as a type 1 diabetes 
       susceptibility gene -- No association of TLR2 and TLR4 
       polymorphisms with type I diabetes mellitus in the Basque 
       population -- Association of SUMO4 M55V polymorphism with 
       autoimmune diabetes in Latvian patients -- A second 
       component of HLA-linked susceptibility to type 1 diabetes 
       maps to class I region -- Molecular scanning of the gene 
       for programmed cell death-1 (PDCD-1) as a candidate for 
       type 1 diabetes susceptibility -- Genetic determinants of 
       type 1 diabetes across populations -- TNFa-e 
       microsatellite, HLA-DRB1 and -DQB1 alleles and haplotypes 
       in Brazilian patients presenting recently diagnosed type 1
       diabetes mellitus -- Is HLA class II profile relevant for 
       the study of large-scale differentially expressed genes in
       type 1 diabetes mellitus patients? -- Feasibility of a 
       type 1 diabetes primary prevention trial using 2000 IU 
       vitamin D3 in infants from the general population with 
       increased HLA-associated risk -- Interleukin-10 plasmid 
       construction and delivery for the prevention of type 1 
       diabetes -- TEDDY--The Environmental Determinants of 
       Diabetes in the Young: an observational clinical trial -- 
       Protection from type 1 diabetes by vitamin D receptor 
       haplotypes -- Living donor islet transplantation, the 
       alternative approach to overcome the obstacles limiting 
       transplant -- DiaPep277 preserves endogenous insulin 
       production by immunomodulation in type 1 diabetes -- Cord 
       blood islet autoantibodies are related to stress in the 
       mother during pregnancy -- Is it dietary insulin? -- 
       Probiotics for the prevention of beta cell autoimmunity in
       children at genetic risk of type 1 diabetes--the PRODIA 
       study -- Thiazolidinediones may not reduce diabetes 
       incidence in type 1 diabetes -- Mechanisms mediating anti-
       CD3 antibody efficacy: insights from a mathematical model 
       of type 1 diabetes -- Why diabetes incidence increases--a 
       unifying theory -- Overcoming the challenges now limiting 
       islet transplantation: a sequential, integrated approach 
530    Also issued in print 
538    Mode of access: World Wide Web 
650  0 Diabetes|xImmunological aspects|vCongresses 
650  0 Immunogenetics|vCongresses 
650 07 Diabetes mellitus|2swd 
650 07 Typ 1|2swd 
650 07 Immunologie|2swd 
650 07 Pathogenese|2swd 
650 07 Autoaggressionskrankheit|2swd 
650 12 Diabetes Mellitus, Type 1|xgenetics|vCongresses 
650 12 Diabetes Mellitus, Type 1|ximmunology|vCongresses 
650 12 Diabetes Mellitus, Type 1|xprevention & control
651  7 Awaji|2swd 
700 1  Sanjeevi, C. B 
700 1  Hanafusa, Toshiaki 
710 2  New York Academy of Sciences 
830  0 Annals of the New York Academy of Sciences ;|vv. 1079  
856 40 |uhttp://onlinelibrary.wiley.com/doi/10.1111/